Spratt P - Search Results

1

Hyperlipidemia after heart transplantation.

Keogh A, Simons L, Spratt P, Esmore D, Chang V, Hickie J, Baron D. Keogh A, et al. Among authors: spratt p. J Heart Transplant. 1988 May-Jun;7(3):171-5. J Heart Transplant. 1988. PMID: 3290399

2

Right ventricular assist and prostacyclin infusion for allograft failure in the presence of high pulmonary vascular resistance.

Esmore DS, Spratt PM, Branch JM, Keogh AM, Lee RP, Farnsworth AE, Shanahan MX, Chang VP. Esmore DS, et al. Among authors: spratt pm. J Heart Transplant. 1990 Mar-Apr;9(2):136-41. J Heart Transplant. 1990. PMID: 2108232

3

Quality of life after heart transplantation in patients assigned to double- or triple-drug therapy.

Jones BM, Taylor FJ, Wright OM, Harvison A, McBride M, Spratt PM, Chang VP. Jones BM, et al. Among authors: spratt pm. J Heart Transplant. 1990 Jul-Aug;9(4):392-6. J Heart Transplant. 1990. PMID: 2204696 Clinical Trial.

4

Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial.

Esmore DS, Spratt PM, Keogh AM, Chang VP. Esmore DS, et al. Among authors: spratt pm. J Heart Transplant. 1989 May-Jun;8(3):194-9. J Heart Transplant. 1989. PMID: 2661768 Clinical Trial.

5

A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation.

Macdonald PS, Keogh AM, Marshman D, Richens D, Harvison A, Kaan AM, Spratt PM. Macdonald PS, et al. Among authors: spratt pm. J Heart Lung Transplant. 1995 Jan-Feb;14(1 Pt 1):32-8. J Heart Lung Transplant. 1995. PMID: 7727473 Clinical Trial.

6

A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation--increased morbidity with OKT3.

Macdonald PS, Mundy J, Keogh AM, Chang VP, Spratt PM. Macdonald PS, et al. Among authors: spratt pm. Transplantation. 1993 Jan;55(1):110-6. doi: 10.1097/00007890-199301000-00021. Transplantation. 1993. PMID: 8380508 Clinical Trial.

7

Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.

Keogh A, Macdonald P, Harvison A, Richens D, Mundy J, Spratt P. Keogh A, et al. Among authors: spratt p. J Heart Lung Transplant. 1992 Mar-Apr;11(2 Pt 2):421-7. J Heart Lung Transplant. 1992. PMID: 1571340 Clinical Trial.

8

Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation.

Keogh A, Macdonald P, Mundy J, Chang V, Harvison A, Spratt P. Keogh A, et al. Among authors: spratt p. J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 1):550-5; discussion 556. J Heart Lung Transplant. 1992. PMID: 1610863 Clinical Trial.

9

Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation.

Spratt P, Sivathasan C, Macdonald P, Keogh A, Chang V. Spratt P, et al. J Heart Lung Transplant. 1991 Nov-Dec;10(6):912-4. J Heart Lung Transplant. 1991. PMID: 1756155

10

Heart transplantation in females.

Esmore D, Keogh A, Spratt P, Jones B, Chang V. Esmore D, et al. Among authors: spratt p. J Heart Lung Transplant. 1991 May-Jun;10(3):335-41. J Heart Lung Transplant. 1991. PMID: 1854761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters